05 Nov Merck CEO 'actively looking' for biotech deals
A day after closing Merck’s $41 billion takeover of Schering-Plough, Merck CEO Dick Clark showed that his appetite for deal-making hasn’t been sated. Clark told us today that the newly combined company is “actively looking” for biotechs to buy or partner with.
For the moment, Clark said doing another mega-deal was “off the table right now” because the company needs to concentrate on combining Merck with Schering-Plough. But Merck is certainly interested in smaller deals, in the “single-digit billions” of dollars, the CEO said, without being more specific. Read More http://blogs.wsj.com/health/2009/11/04/merck-ceo-actively-looking-for-biotech-deals/tab/print/